Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Dennis Slamon Net Worth & Insider Trades

Dennis Slamon - Director, Biomarin Pharmaceutical Inc

As of May 24, 2023

What is Dennis Slamon's Net Worth?

The current estimated net worth of Biomarin Pharmaceutical Inc's Director, Dennis Slamon, is estimated to be about $2.52M . Dennis Slamon owns about 21,639 units of Biomarin Pharmaceutical Inc common stock. In the last 9 years at Biomarin Pharmaceutical Inc, Dennis Slamon has sold an estimated value of $501.01K worth.

What is Dennis Slamon's Past Insider Trading?

Dennis Slamon's largest sale order was 6,396 units , worth over $501.01K on March 2, 2022. In total, Dennis Slamon has made about 11 transactions over 9 years of their time at Biomarin Pharmaceutical Inc. Dennis Slamon usually trades in June, with the busiest year in 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dennis Slamon

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Dennis Slamon's' Mailing Address?

  • Mailing address is 770 Lindaro Street San Rafael CA 94901 CA

What are Biomarin Pharmaceutical Inc's Past Insider Trades?

Biomarin Pharmaceutical Inc's most recent insider trade came on August 17, 2023 by Robert Jeffrey Ajer who sold 5,000 units worth $450K . In the last 20 years, insiders at Biomarin Pharmaceutical Inc have sold an estimated value of $652.7M and bought an estimated value of $180.03M worth of shares. Insider trading is most common in May, with the busiest year in 2008. The most active traders at the company are Jacques Jean Bienaime, Chief Executive Officer,  Eric George Davis, EVP,  and Henry Fuchs, President .

BIOMARIN PHARMACEUTICAL INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...